|

The Effect of a Smartphone-assisted Hybrid Cardiac Rehabilitation Program in Patients With Heart Failure.

RECRUITINGN/ASponsored by National Taiwan University Hospital
Actively Recruiting
PhaseN/A
SponsorNational Taiwan University Hospital
Started2024-01-26
Est. completion2028-12-01
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted

Summary

The aim of this randomized controlled trial is to compare the impact of a case manager-led smartphone-assisted hybrid cardiac rehabilitation program with usual care in patients with HF. Participants will undergo a 12-week program led by a case manager and assisted by a smartphone. The study aims to answer two main questions: 1. Is the novel cardiac rehabilitation model feasible for patients with HF? 2. Does the intervention group show a significant improvement in exercise capacity and adherence compared to the usual care group?

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients with heart failure between the ages of 18 and 80 years old.
* NYHA (New York Heart Association) functional classification of 1 to 3.
* Patients must be in a stable condition and under outpatient follow-up.

Exclusion Criteria:

* Patients who have contraindications for exercise according to the American College of Sports Medicine's Guidelines for Exercise Testing and Prescription.
* Patients who are unable to complete cardiopulmonary exercise testing.
* Patients who are unable to follow verbal instructions.
* Patients who are unable to walk independently or pedal a stationary bicycle.
* Patients who are unable to use communication app on a smartphone.
* Patients who already engage in physical activity exceeding the recommended moderate intensity of 150 minutes per week or are currently participating in cardiac rehabilitation.
* Patients who do not provide consent to participate in the trial.

Conditions2

Heart DiseaseHeart Failure

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.